Positron Emission Tomography Imaging of Dopamine Receptors Using the Tracer [11C]NNC-112

计划入组 10 人 · 首次发布于 2004 年 7 月 28 日

Brain Dopaminergic Signaling in Opioid Use Disorders

计划入组 153 人 · 首次发布于 2017 年 6 月 19 日

Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD)

计划入组 176 人 · 首次发布于 2026 年 4 月 30 日

CPP-11H

11h (Goldenrod Therapeutics)

4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE

C₂₀H₁₅NO₄

UNITE 11

France

HC-116 Eddie Dowling Highway, LLC

United States

Goldenrod Therapeutics Secures $6.5 Million Seed Round to Advance CNS-Penetrant PDE4 Inhibitor Toward 2027 Clinical Trials

ORIC-114 Demonstrates Potential in Preclinical Cancer Study

HMI-115: Novel Endometriosis Drug Allows Pregnancy During Treatment